CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Issues Update on Sol-gel Program
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning issued an updated on its soluble gel (“Sol-gel”) drug delivery research and development program, which involves testing an array of cannabis strains for the development and commercialization of cannabinoid-based Sol-gels. Per the update, the program uses five distinct Cannabis sativa L. strains containing an assortment of CBD:THC concentrations, enabling the development of medicinal cannabis products tailored for a broad range of ailments and diseases. The current focus of the Sol-gel program is on preparing formulations containing fixed CBD:THC concentrations that can be utilized with a custom…